The Ademi Firm is investigating Generation Bio (Nasdaq: GBIO) for breaches of fiduciary duty in a recent transaction.
Milwaukee, December 15, 2025 - The Ademi Firm has initiated an investigation into Generation Bio (Nasdaq: GBIO) concerning potential breaches of fiduciary duty and legal violations related to its recent transaction with XOMA Royalty Corporation. To participate in the investigation, find more information by visiting...
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments